Sprim & Tikehau contribute $50mn toward medtech & life science sectors
Date: 2018-03-13   Author: Dhananjay Punekar  Category: #news

Sprim & Tikehau contribute $50mn toward medtech & life science sectors

Tikehau Capital, a private equity firm headquartered in France, has scarcely formed an association with Sprim Ventures, an investor in early stage health solutions. The alliance aims to introduce a USD 50 million early-phase venture capital fund targeting medtech & life sciences firms in Singapore. Industry analysts speculate that the combined entity referred as TKS1 is planning to provide funds to new firms, whose objective is to deliver effective healthcare solutions. The new establishment is also set up to significantly contribute toward the rapid development of therapeutics.

Tikehau Capital handles nearly EUR 13.8 billion of assets as well as asset classes through its asset management division Tikehau IM. Bruno de Pampelonne, Chairperson of Tikehau IM, has stated that with Singapore emerging as an innovation hub, both Sprim and Tikehau have selected medtech & life science firms as their key VC investment destinations. He further added that supportive government policies, a strong R&D ecosystem, and the presence of numerous research institutes & startups have made the country a global hub for carrying out healthcare research activities.

As per reliable reports, TKS1 has announced that it has already funded five firms, namely, ObvioHealth, Travecta Therapeutics, Evid Science, Fibronostics, and Babynostics. TKS1 is likely to focus on initial-stage investments ranging from USD 5,00,000 to USD 5 million across medtech & life science sectors.

The co-founder of Sprim Ventures, Michael Shleifer has announced that through Tikehau Capital support and its own expertise across the healthcare sector, TKS1 will be able to offer exceptional services to the patients & physicians. He asserted that the strategic partnership will assist both the firms in contributing notably towards the growth of the healthcare industry.

Analysts state that this deal forms a part of the lucrative investments witnessed by the medical care sector since the last few years. AltAssets quotes instances of the same, claiming that KKR raised funds worth USD 598 million for its healthcare program while Lilly Asia Ventures closed its fourth healthcare fund round at USD 450 million recently.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Portable Zirconia Oxygen Analyzer Market Size - Industry Analysis, Share, Growth, Trends, and Forecast 2019-2025
Author: Partha Ray

A report on ' Portable Zirconia Oxygen Analyzer market' Added by Market Study Report, LLC, provides a succinct analysis regarding the values and trends existing in the current business scenario. The study also offers a brief summary of market valu...


Barrier System Market Size, Growth, Analysis, Outlook by 2019 - Trends, Opportunities and Forecast to 2025
Author: Partha Ray

Market Study Report LLC adds new report on Global Barrier System Market Research, which contains company information, geographical data and market analysis about this industry for all stakeholders involved in or wanting to get into this market.


Industrial Lighting Market Size |Incredible Possibilities and Growth Analysis and Forecast To 2025
Author: Partha Ray

Market Study Report, LLC, has recently added a report on ' Industrial Lighting market' which offers a comprehensive synopsis of revolving market valuation, market size, SWOT analysis, revenue estimation and geographical spectrum of the market. The...